BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 24892703)

  • 1. Cellular and molecular mechanisms in kidney fibrosis.
    Duffield JS
    J Clin Invest; 2014 Jun; 124(6):2299-306. PubMed ID: 24892703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of myofibroblasts and cellular events triggering fibrosis.
    Mack M; Yanagita M
    Kidney Int; 2015 Feb; 87(2):297-307. PubMed ID: 25162398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.
    Campanholle G; Ligresti G; Gharib SA; Duffield JS
    Am J Physiol Cell Physiol; 2013 Apr; 304(7):C591-603. PubMed ID: 23325411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease].
    Nakagawa S
    Yakugaku Zasshi; 2017; 137(11):1355-1360. PubMed ID: 29093371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role played by perivascular cells in kidney interstitial injury.
    Rojas A; Chang FC; Lin SL; Duffield JS
    Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding myofibroblast origins in human kidney fibrosis.
    Kuppe C; Ibrahim MM; Kranz J; Zhang X; Ziegler S; Perales-Patón J; Jansen J; Reimer KC; Smith JR; Dobie R; Wilson-Kanamori JR; Halder M; Xu Y; Kabgani N; Kaesler N; Klaus M; Gernhold L; Puelles VG; Huber TB; Boor P; Menzel S; Hoogenboezem RM; Bindels EMJ; Steffens J; Floege J; Schneider RK; Saez-Rodriguez J; Henderson NC; Kramann R
    Nature; 2021 Jan; 589(7841):281-286. PubMed ID: 33176333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.
    Humphreys BD; Lin SL; Kobayashi A; Hudson TE; Nowlin BT; Bonventre JV; Valerius MT; McMahon AP; Duffield JS
    Am J Pathol; 2010 Jan; 176(1):85-97. PubMed ID: 20008127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
    Chang FC; Chou YH; Chen YT; Lin SL
    J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericytes in kidney fibrosis.
    Ren S; Duffield JS
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):471-80. PubMed ID: 23722183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney pericytes: roles in regeneration and fibrosis.
    Kramann R; Humphreys BD
    Semin Nephrol; 2014 Jul; 34(4):374-83. PubMed ID: 25217266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tools to study renal fibrogenesis.
    Liao X; Scheidereit E; Kuppe C
    Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):420-426. PubMed ID: 38587103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of pericytes in kidney fibrosis.
    Kida Y; Duffield JS
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):467-73. PubMed ID: 21517936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction.
    Fligny C; Duffield JS
    Curr Opin Rheumatol; 2013 Jan; 25(1):78-86. PubMed ID: 23196325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
    Kramann R; DiRocco DP; Humphreys BD
    J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney pericytes: a novel therapeutic target in interstitial fibrosis.
    Smith SW; Schrimpf C; Parekh DJ; Venkatachalam M; Duffield JS
    Histol Histopathol; 2012 Dec; 27(12):1503-14. PubMed ID: 23059881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.
    Chang YT; Yang CC; Pan SY; Chou YH; Chang FC; Lai CF; Tsai MH; Hsu HL; Lin CH; Chiang WC; Wu MS; Chu TS; Chen YM; Lin SL
    J Clin Invest; 2016 Feb; 126(2):721-31. PubMed ID: 26731474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts.
    Barnes JL; Glass Ii WF
    Contrib Nephrol; 2011; 169():73-93. PubMed ID: 21252512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of fibrosis: the role of the pericyte.
    Schrimpf C; Duffield JS
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis.
    Vega G; Alarcón S; San Martín R
    Cytokine; 2016 Dec; 88():115-125. PubMed ID: 27599257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation.
    Bijkerk R; de Bruin RG; van Solingen C; van Gils JM; Duijs JM; van der Veer EP; Rabelink TJ; Humphreys BD; van Zonneveld AJ
    Kidney Int; 2016 Jun; 89(6):1268-80. PubMed ID: 27165825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.